# Karel Pavelká

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/karel-pavelka/

## Facts

| Field | Value |
| --- | --- |
| Citations | 44,203 |
| Field | Rheumatoid Arthritis Research and Therapies |
| h-index | 76 |
| i10-index | 257 |
| Last Known Institution | Institute of Rheumatology |
| OpenAlex ID | https://openalex.org/A5089477356 |
| ORCID iD | https://orcid.org/0000-0003-1952-8422 |
| Works | 852 |

## Researcher papers

- [EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update](https://scholariq.org/papers/eular-recommendations-for-the-management-of-rheumatoid-arthritis-with-synthetic/)
- [The PREMIER study: A multicenter, randomized, double‐blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment](https://scholariq.org/papers/the-premier-study-a-multicenter-randomized-double-blind-clinical-trial-of/)
- [\nEULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs.](https://scholariq.org/papers/neular-recommendations-for-the-management-of-rheumatoid-arthritis-with-synthetic/)
- [EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis](https://scholariq.org/papers/eular-recommendations-for-the-non-pharmacological-core-management-of-hip-and/)
- [2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis](https://scholariq.org/papers/2010-update-of-the-asas-eular-recommendations-for-the-management-of-ankylosing/)
- [European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update](https://scholariq.org/papers/european-league-against-rheumatism-eular-recommendations-for-the-management-of/)
- [EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis: 2023 update](https://scholariq.org/papers/eular-recommendations-for-the-non-pharmacological-core-management-of-hip-and-2/)
- [GWAS of clinically defined gout and subtypes identifies multiple susceptibility loci that include urate transporter genes](https://scholariq.org/papers/gwas-of-clinically-defined-gout-and-subtypes-identifies-multiple-susceptibility/)

## Researcher topics

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Osteoarthritis Treatment and Mechanisms](https://scholariq.org/topics/osteoarthritis-treatment-and-mechanisms/)
- [Autoimmune and Inflammatory Disorders Research](https://scholariq.org/topics/autoimmune-and-inflammatory-disorders-research/)
- [Inflammatory mediators and NSAID effects](https://scholariq.org/topics/inflammatory-mediators-and-nsaid-effects/)

## Researcher university

- [Institute of Rheumatology](https://scholariq.org/institutions/institute-of-rheumatology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.